XML 48 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' (Deficiency)/Equity (Details Narrative) (USD $)
6 Months Ended 216 Months Ended 6 Months Ended
Jan. 31, 2014
Jan. 31, 2013
Jan. 31, 2014
Jul. 31, 2013
Jan. 31, 2014
Various Consultants
Jan. 31, 2014
Employee Compensation
Jan. 31, 2014
Series E Convertible Preferred Stock
Jan. 15, 2014
Series E Convertible Preferred Stock
Jan. 31, 2014
Make-Whole Dividend Payments
Jan. 31, 2014
Upon Exercise Of Warrants
Jan. 31, 2014
Upon Exercise Of Options
Jan. 31, 2014
Executives, Directors, Employees
Jan. 31, 2014
Warrant Expiration Date 31 March 2016
Jan. 31, 2014
Warrant Expiration Date 11 July 2016
Jan. 31, 2014
Warrant Expiration Date 30 September 2016
Jan. 31, 2014
Warrant Expiration Date 1 February 2017
Jan. 31, 2014
Warrant Expiration Date 10 August 2017
Jan. 31, 2014
Warrant Expiration Date 12 December 2017
Jan. 31, 2014
Warrant Expiration Date 17 June 2018
Jan. 31, 2014
Total Warrants
Jan. 31, 2014
Board Approved Equity Program
Jan. 31, 2014
Approved In Good Faith
Common stock issued, or committed to issue, Shares         1,233,334 4,333,333 30,166,666   5,201,739 70,732,022 526,306                   5,608,926 11,217,852
Common stock issued, or committed to issue, Amount $ 696,050   $ 696,050 $ 580,329 $ 77,000 $ 130,000   $ 26,666,668   $ 2,121,961                        
Common stock, value per share $ 0.001   $ 0.001 $ 0.001 $ 0.03 $ 0.03       $ 0.03 $ 0.001                      
Common stock, value per share (Maximum)         $ 0.15                                  
Conversion of shares of Series E, Convertible Preferred Stock             905                              
Additional value or warrant exercised                   2,039,599                        
Charge to operations, stock option expense       4,011,938                 5,365                    
Repayment of deferred salaries 257,505   257,505                                      
Cash proceeds                     526                      
Outstanding warrants, weighted average exercise price $ 0.09                                          
Outstanding warrants, weighted average remaining life (in years) 3 years 15 days                                          
Number of shares to be purchased 194,164,585   194,164,585 238,229,939                 69,516,756 1,175,227 27,272,720 5,675,227 4,999,999 8,324,144 34,166,669 26,666,668    
Number of shares to be purchased, exercise price $ 0.03   $ 0.03 $ 0.03                 $ 0.03 $ 0.03 $ 0.03 $ 0.03 $ 0.03 $ 0.03 $ 0.03 $ 0.03    
Percentage of common stock issued and outstanding                                         5.00% 10.00%
Estimated value of warrants 26,666,668                                          
Increase in equity $ 237,566   $ 237,566